News Quantified

SLGL – sol-gel technologies ltd. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream [Yahoo! Finance]

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line [Yahoo! Finance]

Sol-Gel Technologies GAAP EPS of -$1.01 misses by $0.31, revenue of $1.55M misses by $0.85M [Seeking Alpha]

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

3.5%

BEAT

1.6%

BEAT

2.4%

BEAT

Form SC 13D/A Sol-Gel Technologies Filed by: Arkin Moshe

Form 424B3 Sol-Gel Technologies

Form EFFECT Sol-Gel Technologies

Form 6-K Sol-Gel Technologies For: Apr 01

Form POS AM Sol-Gel Technologies

Top News Gainers

12/30 Sol Gel Technologies Ltd (NASDAQ: SLGL) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. 13.6%

7/8 Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea 12.9%

5/28 Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo 10.1%

8/8 Form 6-K Sol-Gel Technologies For: Aug 08 9.9%

3/25 UPDATE -- Sol-Gel Technologies to Present at Upcoming 2020 Solebury Trout Virtual Investor Conference 6.6%

2/19 Sol-Gel to Present at the Cowen 40th Annual Health Care Conference 6.5%

1/7 Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020 [Seeking Alpha] 5.7%

3/19 Sol-Gel Technologies to Report Full Year 2019 Financial Results and Corporate Update 5.5%

4/13 Sol-Gel Technologies Announces Closing of Additional $5.0 Million Investment 5.3%

2/14 Form 6-K Sol-Gel Technologies For: Feb 14 5.2%

Top News Decliners

2/13 Form 6-K Sol-Gel Technologies For: Feb 13 -39.4%

1/2 Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK) -10.0%

11/13 Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update -9.1%

2/6 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. -8.6%

3/9 Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio-Ventures II to Invest in Groundbreaking Pharma and Biotechnology Companies -8.3%

3/6 Form 6-K Sol-Gel Technologies For: Mar 06 -7.3%

2/5 Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020 -6.2%

3/3 Form 6-K Sol-Gel Technologies For: Mar 03 -4.7%

7/18 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock. -4.7%

2/4 Sol Gel Technologies Ltd (NASDAQ: SLGL) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day